MAY 03, 2018 8:00 AM PDT

Fecal Lactoferrin Measurements in Clinical Practice

Speaker
  • Assistant Professor of Pediatrics, Harvard Medical School and Program Director, HMS Fellowship in Pediatric Gastroenterology, Boston Children's Hospital
    Biography
      Dr. Paul Rufo is an Assistant Professor of Pediatrics at Harvard Medical School and the Program Director of the Harvard Medical School Fellowship in Pediatric Gastroenterology and Hepatology at Boston Children's Hospital. He is a Senior Associate in the Center for Inflammatory Bowel at Boston Children's Hospital and is affiliated with Beth Israel Deaconness Medical Center and Brigham & Women's Hospital. His research is focused on the development of new modalities for use in the diagnosis and interval assessment of children and adults with IBD. His research also invovled the development of new therapies for inflammatory bowel disease, as well as quality assurance initiaites in this patient population. Dr. Rufo received his medical degree from the University of Massachusetts Medical School and an MMSc degree from Harvard Medical School.

    Abstract

    DATE:  May 3rd, 2018

    TIME:   8:00 AM PDT, 11:00 AM EDT

    Intestinal inflammation is a hallmark of the inflammatory bowel diseases (IBD), including ulcerative colitis and Crohn's disease.  These chronic autoimmune GI illnesses affect upwards of 3 million children and adults in the United States.  Many of the symptoms in patients with IBD overlap with those observed in patients with irritable bowel syndrome (IBS), a discrete and likely pathogenically pleomorphic gastrointestinal illness. Nonetheless, there is a premium on making a distinction between IBD and IBS as their treatment differs significantly.  Fecal lactoferrin testing is a non-invasive metric that can be used to help differentiate patients presenting with non-specific gastrointestinal symptoms as having either IBD or IBS.  Previous data have demonstrated that fecal lactoferrin levels may also useful in tracking disease activity or assessing response to therapy.  Several factors make lactoferrin a particularly useful biomarker:  it is structurally stable and not sensitive to bacterial proteases in the intestinal lumen, it has a steady baseline with well-defined clinical cutoffs, and has broad applicability as it is reliable in virtually any scenario in which a clinician is trying to discern if a particular patient is presenting with an infectious, autoimmune, or inflammatory gastrointestinal disease. These attributes can be leveraged to provide improve health outcomes while decreasing the economic burden on the healthcare system.

    Learning Objectives:

    • Identify scenarios in which fecal lactoferrin testing may aid in diagnosis
    • Recognize when fecal lactoferrin levels may be useful in tracking disease activity or assessing response to therapy
    • Use fecal lactoferrin biomarkers as a first-step diagnostic strategy to minimize the need for scoping on certain patient populations, like pediatrics, for whom a more non-invasive diagnostic tool is beneficial

    This webinar has been approved for Continuing Education credits.  Please see the following link for more information about the CME credits being provided; CME Credits


    Show Resources
    You May Also Like
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    JUL 22, 2020 10:00 AM PDT
    C.E. CREDITS
    JUL 22, 2020 10:00 AM PDT
    DATE: July 23, 2020 TIME: 10:00 am PDT The SARS-CoV-2 pandemic has taken a toll on many sectors of the medical community. As the pandemic took a grip on the laboratory, the need for diagnost...
    JUN 30, 2020 9:00 AM PDT
    C.E. CREDITS
    JUN 30, 2020 9:00 AM PDT
    DATE: June 30, 2020 TIME: 9:00am PDT, 12:00pm EDT QC laboratories perform a critical role in demonstrating pharmaceutical products are consistently manufactured, safe, potent, and pure. At t...
    AUG 25, 2020 8:00 AM PDT
    C.E. CREDITS
    AUG 25, 2020 8:00 AM PDT
    DATE: August 25, 2020 TIME: 8:00am PDT, 10:00am CDT, 11:00am EDT Recombinant lentivirus (LV) and adeno-associated virus (AAV) are critical components of cell and gene therapies, which show g...
    DEC 15, 2020 10:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    DEC 15, 2020 10:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: December 15, 2020 TIME: 10:00am PST Scientists from Thermo Fisher Scientific will walk us through the world of microorganisms. They will discuss their most recent research on viruses,...
    DEC 02, 2020 8:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    Loading Comments...
    Show Resources
    Attendees
    • See more